{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:22:59Z","timestamp":1790706179447,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Based on the possibility that early-phase florbetaben (E-FBB) brain PET can be a surrogate for brain perfusion imaging, we conducted this study to investigate the clinical utility of E-FBB PET instead of <jats:sup>18<\/jats:sup>F-FDG brain PET.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>This prospective study included 35 patients with clinical suspicion of cognitive decline or dementia and 5 healthy controls. Brain MRI, E-FBB PET, late-phase FBB PET, and FDG PET were acquired. The regional SUV ratios (SUVRs) were calculated by cortical surface region of interest analysis using individual MRI, and relationship between E-FBB and FDG PET was analyzed. All PET scans were scored and analyzed as per visual scoring system, which represent tracer uptake abnormality. Moreover, uptake patterns were analyzed to determine the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 40 subjects, 19 were amyloid-positive and 21 were amyloid-negative on late-phase FBB PET. Cortical surface region of interest analysis conducted for comparing between E-FBB and FDG PET revealed significant correlations (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) for regional SUVR among all brain regions; however, the SUVR values of FDG PET were statistically higher than those of E-FBB PET. Similarly, although the visually rated scores for E-FBB and FDG PET showed significant correlation (<jats:italic toggle=\"yes\">P &lt;<\/jats:italic> 0.0001), it was considered that the tracer uptake was more severely decreased for FDG PET. The disease types, specified by E-FBB and FDG PET, were statistically correlated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>E-FBB PET could potentially be a useful biomarker for the diagnosis of dementia in place of FDG PET. Nevertheless, the severity of the disease was more accurately determined by FDG PET.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002768","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T05:39:46Z","timestamp":1568439586000},"page":"e8-e14","source":"Crossref","is-referenced-by-count":28,"title":["Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET"],"prefix":"10.1097","volume":"45","author":[{"given":"Seung Hyun","family":"Son","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunghun","family":"Kang","sequence":"additional","affiliation":[{"name":"Neurology, School of Medicine, Kyungpook National University, Daegu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Woo","family":"Ko","sequence":"additional","affiliation":[{"name":"Neurology, School of Medicine, Kyungpook National University, Daegu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Neurology, School of Medicine, Kyungpook National University, Daegu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Woo","family":"Lee","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeong-Cheol","family":"Ahn","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaetae","family":"Lee","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uicheul","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Daegu Catholic University, Gyeongsan-si, Gyeongbuk, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Young","family":"Jeong","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,9,13]]},"reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","article-title":"EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2","volume":"36","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20230928","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00259-018-4035-y","article-title":"Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib4-20230928","first-page":"253","article-title":"Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits","volume":"43","year":"2002","journal-title":"J Nucl Med"},{"key":"bib5-20230928","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00259-016-3353-1","article-title":"Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20230928","first-page":"10","article-title":"Combined imaging markers dissociate Alzheimer's disease and frontotemporal lobar degeneration\u2014an ALE meta-analysis","volume":"3","year":"2011","journal-title":"Front Aging Neurosci"},{"key":"bib7-20230928","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.neuroimage.2009.05.037","article-title":"Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients","volume":"47","year":"2009","journal-title":"Neuroimage"},{"key":"bib8-20230928","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0404.1996.tb00374.x","article-title":"SPECT measurements of brain function in dementia; a review","volume":"94","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"bib9-20230928","first-page":"250","article-title":"FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?","volume":"55","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2967\/jnumed.110.083683","article-title":"Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib11-20230928","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib12-20230928","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib13-20230928","first-page":"S4","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","year":"2005","journal-title":"Neurosurgery"},{"key":"bib14-20230928","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","year":"2011","journal-title":"Brain"},{"key":"bib15-20230928","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"bib16-20230928","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","year":"2011","journal-title":"Neurology"},{"key":"bib17-20230928","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"key":"bib18-20230928","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hbm.10062","article-title":"Fast robust automated brain extraction","volume":"17","year":"2002","journal-title":"Hum Brain Mapp"},{"key":"bib19-20230928","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroimage.2004.05.007","article-title":"Fast and robust parameter estimation for statistical partial volume models in brain MRI","volume":"23","year":"2004","journal-title":"Neuroimage"},{"key":"bib20-20230928","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1109\/TMI.2002.806283","article-title":"Automatic \u201cpipeline\u201d analysis of 3-D MRI data for clinical trials: application to multiple sclerosis","volume":"21","year":"2002","journal-title":"IEEE Trans Med Imaging"},{"key":"bib21-20230928","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space","volume":"18","year":"1994","journal-title":"J Comput Assist Tomogr"},{"key":"bib22-20230928","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuroimage.2005.03.036","article-title":"Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification","volume":"27","year":"2005","journal-title":"Neuroimage"},{"key":"bib23-20230928","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/cercor\/bhm244","article-title":"Brain size and cortical structure in the adult human brain","volume":"18","year":"2008","journal-title":"Cereb Cortex"},{"key":"bib24-20230928","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.neuroimage.2006.10.041","article-title":"An unbiased iterative group registration template for cortical surface analysis","volume":"34","year":"2007","journal-title":"Neuroimage"},{"key":"bib25-20230928","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.neuroimage.2006.11.021","article-title":"Pattern classification using principal components of cortical thickness and its discriminative pattern in schizophrenia","volume":"34","year":"2007","journal-title":"Neuroimage"},{"key":"bib26-20230928","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.media.2004.06.009","article-title":"Tuning and comparing spatial normalization methods","volume":"8","year":"2004","journal-title":"Med Image Anal"},{"key":"bib27-20230928","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.nicl.2016.10.005","article-title":"Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases","volume":"14","year":"2017","journal-title":"Neuroimage Clin"},{"key":"bib28-20230928","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M","article-title":"Searching scale space for activation in PET images","volume":"4","year":"1996","journal-title":"Hum Brain Mapp"},{"key":"bib29-20230928","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","year":"2002","journal-title":"Neuroimage"},{"key":"bib30-20230928","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4","article-title":"High-resolution intersubject averaging and a coordinate system for the cortical surface","volume":"8","year":"1999","journal-title":"Hum Brain Mapp"},{"key":"bib31-20230928","doi-asserted-by":"crossref","first-page":"7079","DOI":"10.1523\/JNEUROSCI.17-18-07079.1997","article-title":"Structural and functional analyses of human cerebral cortex using a surface-based atlas","volume":"17","year":"1997","journal-title":"J Neurosci"},{"key":"bib32-20230928","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00304699","article-title":"The human pattern of gyrification in the cerebral cortex","volume":"179","year":"1988","journal-title":"Anat Embryol (Berl)"},{"key":"bib33-20230928","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neuroimage.2006.09.047","article-title":"Spatial accuracy of fMRI activation influenced by volume- and surface-based spatial smoothing techniques","volume":"34","year":"2007","journal-title":"Neuroimage"},{"key":"bib34-20230928","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1007\/s00259-016-3353-1","article-title":"Early [18F] florbetaben and [11C] PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:46:54Z","timestamp":1695872814000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000002768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002768","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,13]]}}}